• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Extracorporeal Blood Purification Is Appropriate in Critically Ill Patients with COVID-19 and Multiorgan Failure: PRO.

作者信息

Chung Kevin K, Olson Stephen W

机构信息

Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland.

Division of Nephrology, Walter Reed National Military Medical Center, Bethesda, Maryland.

出版信息

Kidney360. 2021 Aug 19;3(3):416-418. doi: 10.34067/KID.0006632020. eCollection 2022 Mar 31.

DOI:10.34067/KID.0006632020
PMID:35582175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9034809/
Abstract
摘要

相似文献

1
Extracorporeal Blood Purification Is Appropriate in Critically Ill Patients with COVID-19 and Multiorgan Failure: PRO.体外血液净化适用于患有新冠肺炎和多器官功能衰竭的危重症患者：正方观点。
Kidney360. 2021 Aug 19;3(3):416-418. doi: 10.34067/KID.0006632020. eCollection 2022 Mar 31.
2
Extracorporeal Blood Purification Is Appropriate in Critically Ill Patients with COVID-19 and Multiorgan Failure: COMMENTARY.体外血液净化适用于患有新冠肺炎和多器官功能衰竭的危重症患者：评论
Kidney360. 2021 Aug 19;3(3):423-425. doi: 10.34067/KID.0005242021. eCollection 2022 Mar 31.
3
Extracorporeal Blood Purification Is Appropriate in Critically Ill Patients with COVID-19 and Multiorgan Failure: CON.体外血液净化适用于患有新冠肺炎和多器官功能衰竭的重症患者：反对观点。
Kidney360. 2021 Aug 19;3(3):419-422. doi: 10.34067/KID.0007382020. eCollection 2022 Mar 31.
4
Hemoperfusion as a Potential Treatment for Critically Ill COVID-19 Patients with Cytokine Storm.血液灌流作为治疗重症新冠病毒肺炎细胞因子风暴患者的潜在疗法
Blood Purif. 2021;50(3):405-407. doi: 10.1159/000511391. Epub 2020 Nov 10.
5
Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and Recommendation.《COVID-19 大流行期间危重症患者的体外血液净化和器官支持：专家综述和推荐》
Blood Purif. 2021;50(1):17-27. doi: 10.1159/000508125. Epub 2020 May 26.
6
Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically-ill COVID-19 patients.体外血液净化与危重症 COVID-19 患者的生化和临床变量的改善有关。
Ther Apher Dial. 2022 Apr;26(2):316-329. doi: 10.1111/1744-9987.13730. Epub 2021 Sep 16.
7
Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19.选择合适的对照组对于评估 COVID-19 中的细胞因子风暴至关重要。
In Vivo. 2021 Mar-Apr;35(2):1295-1298. doi: 10.21873/invivo.12381.
8
Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.扩充脐带间充质干细胞（UC-MSCs）作为治疗危重症 COVID-19 患者的一种治疗策略：同情用药的理由。
Pain Physician. 2020 Mar;23(2):E71-E83.
9
Application of extracorporeal therapies in critically ill COVID-19 patients.体外治疗在危重症 COVID-19 患者中的应用。
J Zhejiang Univ Sci B. 2021;22(9):701-717. doi: 10.1631/jzus.B2100344.
10
Incidence and Outcomes of Acute Kidney Injury in Critically Ill Patients with Coronavirus Disease 2019.2019 年冠状病毒病危重症患者急性肾损伤的发生率和结局。
Saudi J Kidney Dis Transpl. 2021 Jan-Feb;32(1):84-91. doi: 10.4103/1319-2442.318551.

引用本文的文献

1
Extracorporeal blood purification benefits in post-caesarean patient with severe acute respiratory distress syndrome due to miliary tuberculosis: a case report.体外血液净化治疗剖宫产术后合并粟粒性肺结核致严重急性呼吸窘迫综合征患者的疗效：1 例报告
J Med Case Rep. 2023 Apr 12;17(1):157. doi: 10.1186/s13256-023-03853-w.
2
Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients.ICU 新冠肺炎患者的体外免疫调节治疗及临床结局
Crit Care Explor. 2022 May 19;4(5):e0694. doi: 10.1097/CCE.0000000000000694. eCollection 2022 May.